[
    {
        "content": "<p>the U.S. Food and Drug Administration released the agency’s first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency’s oversight of AI/ML-based medical software. </p>\n<p><a href=\"https://www.fda.gov/news-events/press-announcements/fda-releases-artificial-intelligencemachine-learning-action-plan\">https://www.fda.gov/news-events/press-announcements/fda-releases-artificial-intelligencemachine-learning-action-plan</a></p>\n<div class=\"message_embed\"><a class=\"message_embed_image\" href=\"https://www.fda.gov/news-events/press-announcements/fda-releases-artificial-intelligencemachine-learning-action-plan\" style=\"background-image: url(https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png)\"></a><div class=\"data-container\"><div class=\"message_embed_title\"><a href=\"https://www.fda.gov/news-events/press-announcements/fda-releases-artificial-intelligencemachine-learning-action-plan\" title=\"FDA Releases Artificial Intelligence/Machine Learning Action Plan\">FDA Releases Artificial Intelligence/Machine Learning Action Plan</a></div><div class=\"message_embed_description\">FDA has released the Artificial Intelligence/Machine Learning- Based Software as a Medical Device Action Plan.</div></div></div>",
        "id": 223619763,
        "sender_full_name": "Ricardo Chavarriaga (CLAIRE Office Switzerland)",
        "timestamp": 1611308436
    }
]